Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy BioCryst Pharmaceuticals stock
Learn how to easily invest in BioCryst Pharmaceuticals stock.
BioCryst Pharmaceuticals Inc is a biotechnology business based in the US. BioCryst Pharmaceuticals shares (BCRX) are listed on the NASDAQ and all prices are listed in US Dollars. BioCryst Pharmaceuticals employs 358 staff and has a trailing 12-month revenue of around $203.6 million.
How to buy shares in BioCryst Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BCRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
BioCryst Pharmaceuticals stock price (NASDAQ: BCRX)Use our graph to track the performance of BCRX stocks over time.
BioCryst Pharmaceuticals shares at a glance
|Latest market close||$12.60|
|52-week range||$7.61 - $19.99|
|50-day moving average||$13.16|
|200-day moving average||$13.07|
|Wall St. target price||$18.30|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.07|
Buy BioCryst Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy BioCryst Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
BioCryst Pharmaceuticals price performance over time
|1 week (2022-09-26)||4.05%|
|1 month (2022-09-02)||-10.45%|
|3 months (2022-07-01)||16.24%|
|6 months (2022-04-01)||-24.05%|
|1 year (2021-10-01)||-8.23%|
|2 years (2020-10-02)||273.89%|
|3 years (2019-10-03)||364.94%|
|5 years (2017-10-02)||136.40%|
BioCryst Pharmaceuticals financials
|Revenue TTM||$203.6 million|
|Gross profit TTM||$-58,902,000|
|Return on assets TTM||-28.79%|
|Return on equity TTM||-1925.37%|
|Market capitalisation||$2.4 billion|
TTM: trailing 12 months
BioCryst Pharmaceuticals share dividends
We're not expecting BioCryst Pharmaceuticals to pay a dividend over the next 12 months.
BioCryst Pharmaceuticals share price volatility
Over the last 12 months, BioCryst Pharmaceuticals's shares have ranged in value from as little as $7.61 up to $19.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioCryst Pharmaceuticals's is 2.0771. This would suggest that BioCryst Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
BioCryst Pharmaceuticals overview
BioCryst Pharmaceuticals, Inc. , a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co. , Ltd. ; Seqirus UK Limited; Shionogi & Co.
BioCryst Pharmaceuticals in the news
Got $3,000? Here Are 2 Stocks That Will Make You Richer
3 Biotech Stocks to Buy Now for Extraordinary Gains
BioCryst Names Dr. Bill Sheridan Chief Development Officer and Appoints Dr. Ryan Arnold Chief Medical Officer
Frequently asked questionsWhat percentage of BioCryst Pharmaceuticals is owned by insiders or institutions?
Currently 0.966% of BioCryst Pharmaceuticals shares are held by insiders and 83.013% by institutions. How many people work for BioCryst Pharmaceuticals?
Latest data suggests 358 work at BioCryst Pharmaceuticals. When does the fiscal year end for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals's fiscal year ends in December. Where is BioCryst Pharmaceuticals based?
BioCryst Pharmaceuticals's address is: 4505 Emperor Boulevard, Durham, NC, United States, 27703 What is BioCryst Pharmaceuticals's ISIN number?
BioCryst Pharmaceuticals's international securities identification number is: US09058V1035 What is BioCryst Pharmaceuticals's CUSIP number?
BioCryst Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 09058V103
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert